BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007;8:373-99. [PMID: 17470414 DOI: 10.1016/j.sleep.2007.03.008] [Cited by in Crossref: 122] [Cited by in F6Publishing: 85] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Chokroverty S. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2008. pp. 1947-2009. [DOI: 10.1016/b978-0-7506-7525-3.50110-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
3 Rosenberg R, Kim AY. The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad Med 2014;126:78-86. [PMID: 24393754 DOI: 10.3810/pgm.2014.01.2727] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
4 Boulos MI, Murray BJ. Current Evaluation and Management of Excessive Daytime Sleepiness. Can j neurol sci 2010;37:167-76. [DOI: 10.1017/s0317167100009896] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
5 Likhachev SA, Chechyk NM, Haliyeuskaya OV, Rushkevich YN. [Psychogenically induced narcolepsy]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:99-104. [PMID: 31626225 DOI: 10.17116/jnevro201911909199] [Reference Citation Analysis]
6 Fishman O, Sogawa Y, Moshé SL. Transient axial hypotonia and alteration of consciousness in an infant with Chiari I malformation. Semin Pediatr Neurol 2010;17:17-23. [PMID: 20434687 DOI: 10.1016/j.spen.2010.01.006] [Reference Citation Analysis]
7 Bosch OG, Quednow BB, Seifritz E, Wetter TC. Reconsidering GHB: orphan drug or new model antidepressant? J Psychopharmacol 2012;26:618-28. [DOI: 10.1177/0269881111421975] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
8 Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother 2010;11:1633-45. [PMID: 20426704 DOI: 10.1517/14656566.2010.484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
9 de Sá JF, Mota-Rolim SA. Sleep Paralysis in Brazilian Folklore and Other Cultures: A Brief Review. Front Psychol 2016;7:1294. [PMID: 27656151 DOI: 10.3389/fpsyg.2016.01294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kakizaki M, Tsuneoka Y, Takase K, Kim SJ, Choi J, Ikkyu A, Abe M, Sakimura K, Yanagisawa M, Funato H. Differential Roles of Each Orexin Receptor Signaling in Obesity. iScience 2019;20:1-13. [PMID: 31546102 DOI: 10.1016/j.isci.2019.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
11 Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
12 Chen W, Ye J, Han D, Yin G, Wang B, Zhang Y. Association of prepro-orexin polymorphism with obstructive sleep apnea/hypopnea syndrome. Am J Otolaryngol 2012;33:31-6. [PMID: 21371780 DOI: 10.1016/j.amjoto.2010.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Feldman NT. Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing. Sleep Breath 2010;14:77-9. [PMID: 19626356 DOI: 10.1007/s11325-009-0283-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
14 Ono H, Kanbayashi T, Imanishi A, Ayabe T, Sagawa Y, Tsutsui K, Ohmori Y, Takeshima M, Nishino S, Shimizu T. Clinical characteristics of symptomatic narcolepsy or hypersomnia: an analysis of 182 consecutive cases with neurological disorders associated with hypersomnolence. Sleep Biol Rhythms 2019;17:123-40. [DOI: 10.1007/s41105-018-0186-2] [Reference Citation Analysis]
15 Plazzi G, Ferri R, Antelmi E, Bayard S, Franceschini C, Cosentino FI, Abril B, Spruyt K, Provini F, Montagna P, Dauvilliers Y. Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep 2010;33:689-94. [PMID: 20469811 DOI: 10.1093/sleep/33.5.689] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
16 El Firar A, Voisin T, Rouyer-fessard C, Ostuni MA, Couvineau A, Laburthe M. Discovery of a functional immunoreceptor tyrosine‐ based switch motif in a 7‐transmembrane‐spanning receptor: role in the orexin receptor OX1R‐driven apoptosis. FASEB j 2009;23:4069-80. [DOI: 10.1096/fj.09-131367] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
17 Nevsimalova S. Narcolepsy in childhood. Sleep Medicine Reviews 2009;13:169-80. [DOI: 10.1016/j.smrv.2008.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
18 Tiwari AK, Brandl EJ, Zai CC, Goncalves VF, Chowdhury NI, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. The World Journal of Biological Psychiatry 2015;17:221-9. [DOI: 10.3109/15622975.2015.1076173] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
19 Laposky AD, Bradley MA, Williams DL, Bass J, Turek FW. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 2008;295:R2059-66. [PMID: 18843095 DOI: 10.1152/ajpregu.00026.2008] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 5.9] [Reference Citation Analysis]
20 Chokroverty S, Avidan AY. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2012. pp. 1634-702. [DOI: 10.1016/b978-1-4377-0434-1.00093-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
21 de Martin Truzzi G, Naufel MF, Tufik S, Coelho FM. The influence of narcolepsy on olfactory function: a review. Sleep Med 2020;72:75-81. [PMID: 32554327 DOI: 10.1016/j.sleep.2020.03.023] [Reference Citation Analysis]
22 Kallweit U, Schmidt M, Bassetti CL. Patient-Reported Measures of Narcolepsy: The Need for Better Assessment. J Clin Sleep Med 2017;13:737-44. [PMID: 28162143 DOI: 10.5664/jcsm.6596] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Faraco J, Mignot E. Genetics of Narcolepsy. Sleep Medicine Clinics 2011;6:217-28. [DOI: 10.1016/j.jsmc.2011.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Fenichel GM. Paroxysmal Disorders. Clinical Pediatric Neurology. Elsevier; 2009. pp. 1-48. [DOI: 10.1016/b978-1-4160-6185-4.00001-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Heidmann B, Gatfield J, Roch C, Treiber A, Tortoioli S, Brotschi C, Williams JT, Bolli MH, Abele S, Sifferlen T, Jenck F, Boss C. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach. ChemMedChem 2016;11:2132-46. [DOI: 10.1002/cmdc.201600175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
26 Nevsimalova S, Pisko J, Buskova J, Kemlink D, Prihodova I, Sonka K, Skibova J. Narcolepsy: clinical differences and association with other sleep disorders in different age groups. J Neurol 2013;260:767-75. [DOI: 10.1007/s00415-012-6702-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
27 Sigurgeirsson B, þorsteinsson H, Arnardóttir H, Jóhannesdóttir IÞ, Karlsson KÆ. Effects of Modafinil on Sleep–Wake Cycles in Larval Zebrafish. Zebrafish 2011;8:133-40. [DOI: 10.1089/zeb.2011.0708] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
28 Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui M, Katsuki H. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci 2013;33:12557-68. [PMID: 23904594 DOI: 10.1523/JNEUROSCI.0595-13.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
29 Kodadek T, Cai D. Chemistry and biology of orexin signaling. Mol Biosyst 2010;6:1366-75. [PMID: 20532299 DOI: 10.1039/c003468a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
30 Bauer CT, Banks ML, Blough BE, Negus SS. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 2013;168:850-62. [PMID: 22978626 DOI: 10.1111/j.1476-5381.2012.02214.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 9.1] [Reference Citation Analysis]
31 Kothare SV, Kaleyias J. Narcolepsy and other hypersomnias in children. Curr Opin Pediatr 2008;20:666-75. [PMID: 19023917 DOI: 10.1097/mop.0b013e328316bd85] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
32 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Cao M, Guilleminault C. Hypocretin and its emerging role as a target for treatment of sleep disorders. Curr Neurol Neurosci Rep 2011;11:227-34. [PMID: 21170610 DOI: 10.1007/s11910-010-0172-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
34 Mehr JB, Mitchison D, Bowrey HE, James MH. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link. Neuropsychopharmacology 2021. [PMID: 34145404 DOI: 10.1038/s41386-021-01052-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 De la Herrán-arita AK, Equihua-benítez AC, Drucker-colín R. Treatment of cataplexy. Expert Opinion on Orphan Drugs 2013;1:199-210. [DOI: 10.1517/21678707.2013.765359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Coleman PJ, Renger JJ. Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin Ther Pat 2010;20:307-24. [PMID: 20180618 DOI: 10.1517/13543770903567085] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
37 Nagahara T, Saitoh T, Kutsumura N, Irukayama-Tomobe Y, Ogawa Y, Kuroda D, Gouda H, Kumagai H, Fujii H, Yanagisawa M, Nagase H. Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists. J Med Chem 2015;58:7931-7. [PMID: 26267383 DOI: 10.1021/acs.jmedchem.5b00988] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
38 Braunstein GD. The Hypothalamus. The Pituitary. Elsevier; 2011. pp. 303-41. [DOI: 10.1016/b978-0-12-380926-1.10009-4] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
39 Brown LK, Arora M. Nonrespiratory sleep disorders found in ICU patients. Crit Care Clin 2008;24:589-611, viii. [PMID: 18538202 DOI: 10.1016/j.ccc.2008.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Akins BE, Miranda E, Matthew Lacy J, Logan BK. A Multi-Drug Intoxication Fatality Involving Xyrem ® (GHB). Journal of Forensic Sciences 2009;54:495-6. [DOI: 10.1111/j.1556-4029.2008.00965.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
41 Lacaux C, Izabelle C, Santantonio G, De Villèle L, Frain J, Lubart T, Pizza F, Plazzi G, Arnulf I, Oudiette D. Increased creative thinking in narcolepsy. Brain 2019;142:1988-99. [PMID: 31143939 DOI: 10.1093/brain/awz137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
42 Revell VL, Della Monica C, Mendis J, Hassanin H, Halter RJ, Chaplan SR, Dijk DJ. Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial. Neuropsychopharmacology 2021. [PMID: 34628482 DOI: 10.1038/s41386-021-01175-3] [Reference Citation Analysis]
43 Szabadi E. GHB for cataplexy: Possible mode of action. J Psychopharmacol 2015;29:744-9. [DOI: 10.1177/0269881115573807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
44 Roth T, Dauvilliers Y, Mignot E, Montplaisir J, Paul J, Swick T, Zee P. Disrupted nighttime sleep in narcolepsy. J Clin Sleep Med 2013;9:955-65. [PMID: 23997709 DOI: 10.5664/jcsm.3004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 12.0] [Reference Citation Analysis]
45 Ruoff C, Rye D. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Current Medical Research and Opinion 2016;32:1611-22. [DOI: 10.1080/03007995.2016.1208643] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
46 Thorpy MJ, Ohayon MM, Carls G, Black J, Pasta DJ, Hyman DL, Villa KF. Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4). Sleep Med 2021;84:380-8. [PMID: 34247126 DOI: 10.1016/j.sleep.2021.06.010] [Reference Citation Analysis]
47 Polvi A, Siren A, Kallela M, Rantala H, Artto V, Sobel EM, Palotie A, Lehesjoki AE, Wessman M. Shared loci for migraine and epilepsy on chromosomes 14q12-q23 and 12q24.2-q24.3. Neurology 2012;78:202-9. [PMID: 22218271 DOI: 10.1212/WNL.0b013e31823fcd87] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
48 Alóe F, Alves RC, Araújo JF, Azevedo A, Bacelar A, Bezerra M, Bittencourt LR, Bustamante G, Cardoso TA, Eckeli AL, Fernandes RM, Goulart L, Pradella-Hallinan M, Hasan R, Sander HH, Pinto LR Jr, Lopes MC, Minhoto GR, Moraes W, Moreira GA, Pachito D, Pedrazolli M, Poyares D, Prado L, Rizzo G, Rodrigues RN, Roitman I, Silva AB, Tavares SM. [Brazilian guidelines for the diagnosis of narcolepsy]. Braz J Psychiatry 2010;32:294-304. [PMID: 20585744 DOI: 10.1590/s1516-44462010005000014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
49 Crowley RK, Woods C, Fleming M, Rogers B, Behan LA, O'Sullivan EP, Kane T, Agha A, Smith D, Costello RW, Thompson CJ. Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable. Clin Endocrinol (Oxf) 2011;74:750-5. [PMID: 21521265 DOI: 10.1111/j.1365-2265.2011.03993.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
50 Mo Q, Lu S, Garippa C, Brownstein MJ, Simon NG. Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. J Steroid Biochem Mol Biol 2009;114:135-43. [PMID: 19429443 DOI: 10.1016/j.jsbmb.2009.01.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
51 Faraco J, Mignot E. Immunological and Genetic Aspects of Narcolepsy. Sleep Med Res 2011;2:39-47. [DOI: 10.17241/smr.2011.2.2.39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Theofilas P, Heinsen H, Grinberg LT. Brainstem Circuitry and Emotions. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Elsevier; 2016. pp. 317-26. [DOI: 10.1016/b978-0-12-800105-9.00020-2] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
53 Feneberg E, Steinacker P, Lehnert S, Böhm B, Mayer G, Otto M. Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy. Sleep Medicine 2013;14:692-4. [DOI: 10.1016/j.sleep.2013.04.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
54 Bellebaum C, Daum I. Memory and Cognition in Narcolepsy. In: Goswami M, Pandi-perumal SR, Thorpy MJ, editors. Narcolepsy. New York: Springer; 2010. pp. 223-9. [DOI: 10.1007/978-1-4419-0854-4_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, Clark E, Yamamoto M, Scammell TE. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep 2013;36:1129-38. [PMID: 23904672 DOI: 10.5665/sleep.2870] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
56 Kumar R, Bose A, Mallick BN. A mathematical model towards understanding the mechanism of neuronal regulation of wake-NREMS-REMS states. PLoS One. 2012;7:e42059. [PMID: 22905114 DOI: 10.1371/journal.pone.0042059] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
57 Seoane-Collazo P, Diéguez C, Nogueiras R, Rahmouni K, Fernández-Real JM, López M. Nicotine' actions on energy balance: Friend or foe? Pharmacol Ther 2021;219:107693. [PMID: 32987056 DOI: 10.1016/j.pharmthera.2020.107693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Tannenbaum PL, Stevens J, Binns J, Savitz AT, Garson SL, Fox SV, Coleman P, Kuduk SD, Gotter AL, Marino M, Tye SJ, Uslaner JM, Winrow CJ, Renger JJ. Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Front Behav Neurosci 2014;8:182. [PMID: 24904334 DOI: 10.3389/fnbeh.2014.00182] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
59 Didato G, Nobili L. Treatment of narcolepsy. Expert Rev Neurother 2009;9:897-910. [PMID: 19496692 DOI: 10.1586/ern.09.29] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
60 Jiménez-Genchi A, Avila-Rodríguez VM, Sánchez-Rojas F, Terrez BE, Nenclares-Portocarrero A. Sleep paralysis in adolescents: the 'a dead body climbed on top of me' phenomenon in Mexico. Psychiatry Clin Neurosci 2009;63:546-9. [PMID: 19496997 DOI: 10.1111/j.1440-1819.2009.01984.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
61 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
62 Bhat A, El Solh AA. Management of narcolepsy. Expert Opin Pharmacother 2008;9:1721-33. [PMID: 18570605 DOI: 10.1517/14656566.9.10.1721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
63 Mamelak M. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 2009;89:193-219. [PMID: 19654034 DOI: 10.1016/j.pneurobio.2009.07.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
64 Dong Y, Li M, Wang S, Dong Y, Zhao H, Dai Z. Xingshentongqiao decoction mediates proliferation, apoptosis, orexin-A receptor and orexin-B receptor messenger ribonucleic acid expression and represses mitogen-activated protein kinase signaling. Chin Med J (Engl) 2015;128:98-104. [PMID: 25563321 DOI: 10.4103/0366-6999.147826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Swick TJ. Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep 2015;7:159-69. [PMID: 26715865 DOI: 10.2147/NSS.S92140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
66 Son DY, Kwon HB, Lee DS, Jin HW, Jeong JH, Kim J, Choi SH, Yoon H, Lee MH, Lee YJ, Park KS. Changes in physiological network connectivity of body system in narcolepsy during REM sleep. Comput Biol Med 2021;136:104762. [PMID: 34399195 DOI: 10.1016/j.compbiomed.2021.104762] [Reference Citation Analysis]
67 Ma S, Wu T, Pi G. Sleep paralysis in Chinese adolescents: A representative survey: Sleep paralysis epidemiological survey. Sleep and Biological Rhythms 2014;12:46-52. [DOI: 10.1111/sbr.12045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
68 Perriol Μ-, Cartigny M, Lamblin M, Poirot I, Weill J, Derambure P, Monaca C. Childhood-Onset Narcolepsy, Obesity and Puberty in Four Consecutive Children: A Close Temporal Link. Journal of Pediatric Endocrinology and Metabolism 2010;23. [DOI: 10.1515/jpem.2010.23.3.257] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Joshi PA, Poduri A, Kothare SV. Juvenile myoclonic epilepsy and narcolepsy: A series of three cases. Epilepsy & Behavior 2015;51:163-5. [DOI: 10.1016/j.yebeh.2015.07.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T, Yanagisawa M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 2009;9:64-76. [PMID: 19117547 DOI: 10.1016/j.cmet.2008.10.010] [Cited by in Crossref: 176] [Cited by in F6Publishing: 173] [Article Influence: 13.5] [Reference Citation Analysis]
71 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
72 Winkelmann J, Kimura M. Genetics of sleep disorders. Handb Clin Neurol 2011;99:681-93. [PMID: 21056223 DOI: 10.1016/B978-0-444-52007-4.00002-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
73 Cirelli C. The genetic and molecular regulation of sleep: from fruit flies to humans. Nat Rev Neurosci 2009;10:549-60. [PMID: 19617891 DOI: 10.1038/nrn2683] [Cited by in Crossref: 225] [Cited by in F6Publishing: 194] [Article Influence: 17.3] [Reference Citation Analysis]
74 Biegańska K, Sokołowska P, Jöhren O, Zawilska JB. Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism. J Mol Neurosci 2012;48:706-12. [PMID: 22588980 DOI: 10.1007/s12031-012-9799-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
75 Kalogiannis M, Hsu E, Willie JT, Chemelli RM, Kisanuki YY, Yanagisawa M, Leonard CS. Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice. PLoS One 2011;6:e18697. [PMID: 21533254 DOI: 10.1371/journal.pone.0018697] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
76 Nevsimalova S, Jara C, Prihodova I, Kemlink D, Sonka K, Skibova J. Clinical features of childhood narcolepsy. Can cataplexy be foretold? Eur J Paediatr Neurol 2011;15:320-5. [PMID: 21345702 DOI: 10.1016/j.ejpn.2011.01.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
77 Girardin M, Ouellet SG, Gauvreau D, Moore JC, Hughes G, Devine PN, O’shea PD, Campeau L. Convergent Kilogram-Scale Synthesis of Dual Orexin Receptor Antagonist. Org Process Res Dev 2013;17:61-8. [DOI: 10.1021/op3002678] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
78 Cavaliere C, Longarzo M, Fogel S, Engström M, Soddu A. Neuroimaging of Narcolepsy and Primary Hypersomnias. Neuroscientist 2020;26:310-27. [PMID: 32111133 DOI: 10.1177/1073858420905829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
79 Chen L, Brown RE, McKenna JT, McCarley RW. Animal models of narcolepsy. CNS Neurol Disord Drug Targets 2009;8:296-308. [PMID: 19689311 DOI: 10.2174/187152709788921717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
80 Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Medicine 2014;15:502-7. [DOI: 10.1016/j.sleep.2014.01.015] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 13.5] [Reference Citation Analysis]
81 Cao M. Advances in narcolepsy. Med Clin North Am 2010;94:541-55. [PMID: 20451031 DOI: 10.1016/j.mcna.2010.02.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
82 Nepovimova E, Janockova J, Misik J, Kubik S, Stuchlik A, Vales K, Korabecny J, Mezeiova E, Dolezal R, Soukup O, Kobrlova T, Pham NL, Nguyen TD, Konecny J, Kuca K. Orexin supplementation in narcolepsy treatment: A review. Med Res Rev 2019;39:961-75. [PMID: 30426515 DOI: 10.1002/med.21550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
83 Aguilar AC, Frange C, Pimentel Filho LH, Reis MJ, Tufik S, Coelho FMS. Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series. Braz J Psychiatry 2020;42:314-6. [PMID: 31859793 DOI: 10.1590/1516-4446-2019-0544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Dugovic C, Shelton JE, Yun S, Bonaventure P, Shireman BT, Lovenberg TW. Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism. Front Neurosci 2014;8:28. [PMID: 24592208 DOI: 10.3389/fnins.2014.00028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
85 Baier PC, Weinhold SL, Huth V, Gottwald B, Ferstl R, Hinze-Selch D. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1). Brain 2008;131:2734-41. [PMID: 18718966 DOI: 10.1093/brain/awn193] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
86 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
87 Cipolli C, Campana G, Campi C, Mattarozzi K, Mazzetti M, Tuozzi G, Vandi S, Vignatelli L, Plazzi G. Sleep and time course of consolidation of visual discrimination skills in patients with narcolepsy-cataplexy. J Sleep Res 2009;18:209-20. [PMID: 19302342 DOI: 10.1111/j.1365-2869.2008.00712.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
88 Gestreau C, Bévengut M, Dutschmann M. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive. Curr Opin Pulm Med 2008;14:512-8. [PMID: 18812827 DOI: 10.1097/MCP.0b013e32831311d3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]